HSBC Holdings’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $745K | Buy |
90,804
+34,989
| +63% | +$287K | ﹤0.01% | 1524 |
|
|
2025
Q1 | $390K | Sell |
55,815
-29,002
| -34% | -$203K | ﹤0.01% | 1776 |
|
|
2024
Q4 | $629K | Buy |
84,817
+48,310
| +132% | +$358K | ﹤0.01% | 1665 |
|
|
2024
Q3 | $376K | Buy |
36,507
+16,591
| +83% | +$171K | ﹤0.01% | 1818 |
|
|
2024
Q2 | $234K | Buy |
19,916
+5,389
| +37% | +$63.4K | ﹤0.01% | 2101 |
|
|
2024
Q1 | $306K | Sell |
14,527
-13,618
| -48% | -$287K | ﹤0.01% | 2031 |
|
|
2023
Q4 | $504K | Sell |
28,145
-2,437
| -8% | -$43.6K | ﹤0.01% | 1629 |
|
|
2023
Q3 | $511K | Sell |
30,582
-6,889
| -18% | -$115K | ﹤0.01% | 1536 |
|
|
2023
Q2 | $757K | Buy |
37,471
+6,391
| +21% | +$129K | ﹤0.01% | 1447 |
|
|
2023
Q1 | $578K | Buy |
31,080
+14,585
| +88% | +$271K | ﹤0.01% | 1590 |
|
|
2022
Q4 | $368K | Buy |
16,495
+4,276
| +35% | +$95.4K | ﹤0.01% | 1978 |
|
|
2022
Q3 | $328K | Buy |
12,219
+3,813
| +45% | +$102K | ﹤0.01% | 1950 |
|
|
2022
Q2 | $210K | Sell |
8,406
-1,127
| -12% | -$28.2K | ﹤0.01% | 2438 |
|
|
2022
Q1 | $321K | Buy |
+9,533
| New | +$321K | ﹤0.01% | 2350 |
|
|
2021
Q3 | – | Sell |
-7,788
| Closed | -$308K | – | 2628 |
|
|
2021
Q2 | $308K | Sell |
7,788
-6,275
| -45% | -$248K | ﹤0.01% | 2078 |
|
|
2021
Q1 | $480K | Buy |
+14,063
| New | +$480K | ﹤0.01% | 1664 |
|
|
2020
Q3 | – | Sell |
-44,578
| Closed | -$1.64M | – | 2342 |
|
|
2020
Q2 | $1.64M | Buy |
+44,578
| New | +$1.64M | ﹤0.01% | 959 |
|
|
2020
Q1 | – | Sell |
-5,283
| Closed | -$217K | – | 2416 |
|
|
2019
Q4 | $217K | Sell |
5,283
-1,738
| -25% | -$71.4K | ﹤0.01% | 2226 |
|
|
2019
Q3 | $250K | Buy |
7,021
+883
| +14% | +$31.4K | ﹤0.01% | 2163 |
|
|
2019
Q2 | $316K | Buy |
6,138
+829
| +16% | +$42.7K | ﹤0.01% | 1735 |
|
|
2019
Q1 | $304K | Buy |
+5,309
| New | +$304K | ﹤0.01% | 1811 |
|